JAM3: A prognostic biomarker for bladder cancer via epithelial–mesenchymal transition regulation. Biomol Biomed [Internet]. 2024 Feb. 23 [cited 2025 Apr. 17];24(4):897-911. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/9979